{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T03:05:16Z","timestamp":1768014316910,"version":"3.49.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T00:00:00Z","timestamp":1530576000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Cardiovasc Drugs"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s40256-018-0290-3","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T05:57:34Z","timestamp":1530597454000},"page":"415-422","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Association Between High-Dose Spironolactone and Decongestion in Patients with Acute Heart Failure: An Observational Retrospective Study"],"prefix":"10.1007","volume":"18","author":[{"given":"Chris J.","family":"Kapelios","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Bonou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Vogiatzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Tzanis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Polyxeni","family":"Mantzouratou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars H.","family":"Lund","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Barbetseas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,7,3]]},"reference":[{"key":"290_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.ahj.2004.08.005","volume":"149","author":"KF Adams","year":"2005","unstructured":"Adams KF, Fonarow GC, Emerman CL, LeJemtel TH, Costanzo MR, Abraham WT, Berkowitz RL, Galvao M, Horton DP, for the ADHERE Scientific Advisory Committee and Investigators. Characteristics and outcomes of patients hospitalized for heart failure in the United States: rationale, design, and preliminary observations from the first 100,000 cases in the Acute Decompensated Heart Failure National Registry (ADHERE). Am Heart J. 2005;149:209\u201316.","journal-title":"Am Heart J"},{"key":"290_CR2","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1161\/CIRCHEARTFAILURE.114.001957","volume":"8","author":"A Lala","year":"2015","unstructured":"Lala A, McNulty SE, Mentz RJ, Dunlay SM, Vader JM, AbouEzzeddine OF, DeVore AD, Khazanie P, Redfield MM, Goldsmith SR, Bart BA, Anstrom KJ, Felker GM, Hernandez AF, Stevenson LW. Relief and recurrence of congestion during and after hospitalization for acute heart failure: insights from Diuretic Optimization Strategy Evaluation in Acute Decompensated Heart Failure (DOSE-AHF) and Cardiorenal Rescue Study in Acute Decompensated Heart Failure (CARESS-HF). Circ Heart Fail. 2015;8:741\u20138.","journal-title":"Circ Heart Fail"},{"key":"290_CR3","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1001\/jama.297.12.1332","volume":"297","author":"M Gheorghiade","year":"2007","unstructured":"Gheorghiade M, Konstam MA, Burnett JC Jr, Grinfeld L, Maggioni AP, Swedberg K, Udelson JE, Zannad F, Cook T, Ouyang J, Zimmer C, Orlandi C. Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure: the EVEREST Clinical Status Trials. JAMA. 2007;297:1332\u201343.","journal-title":"JAMA"},{"issue":"23","key":"290_CR4","doi-asserted-by":"publisher","first-page":"2533","DOI":"10.1001\/jama.2013.282190","volume":"310","author":"HH Chen","year":"2013","unstructured":"Chen HH, Anstrom KJ, Givertz MM, Stevenson LW, Semigran MJ, Goldsmith SR, Bart BA, Bull DA, Stehlik J, LeWinter MM, Konstam MA, Huggins GS, Rouleau JL, O\u2019Meara E, Tang WH, Starling RC, Butler J, Deswal A, Felker GM, O\u2019Connor CM, Bonita RE, Margulies KB, Cappola TP, Ofili EO, Mann DL, D\u00e1vila-Rom\u00e1n VG, McNulty SE, Borlaug BA, Velazquez EJ, Lee KL, Shah MR, Hernandez AF, Braunwald E, Redfield MM, NHLBI Heart Failure Clinical Research Network. Low-dose dopamine or low-dose nesiritide in acute heart failure with renal dysfunction: the ROSE acute heart failure randomized trial. JAMA. 2013;310(23):2533\u201343.","journal-title":"JAMA"},{"issue":"11","key":"290_CR5","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1002\/ejhf.170","volume":"16","author":"AA Voors","year":"2014","unstructured":"Voors AA, Davison BA, Teerlink JR, Felker GM, Cotter G, Filippatos G, Greenberg BH, Pang PS, Levin B, Hua TA, Severin T, Ponikowski P. Metra M; RELAX-AHF Investigators. Diuretic response in patients with acute decompensated heart failure: characteristics and clinical outcome\u2014an analysis from RELAX-AHF. Eur J Heart Fail. 2014;16(11):1230\u201340.","journal-title":"Eur J Heart Fail"},{"issue":"24","key":"290_CR6","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1056\/NEJMoa1210357","volume":"367","author":"BA Bart","year":"2012","unstructured":"Bart BA, Goldsmith SR, Lee KL, Givertz MM, O\u2019Connor CM, Bull DA, Redfield MM, Deswal A, Rouleau JL, LeWinter MM, Ofili EO, Stevenson LW, Semigran MJ, Felker GM, Chen HH, Hernandez AF, Anstrom KJ, McNulty SE, Velazquez EJ, Ibarra JC, Mascette AM, Braunwald E, Heart Failure Clinical Research Network. Ultrafiltration in decompensated heart failure with cardiorenal syndrome. N Engl J Med. 2012;367(24):2296\u2013304.","journal-title":"N Engl J Med"},{"issue":"4","key":"290_CR7","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1161\/CIRCHEARTFAILURE.108.821199","volume":"2","author":"S Bansal","year":"2009","unstructured":"Bansal S, Lindenfeld J, Schrier RW. Sodium retention in heart failure and cirrhosis: potential role of natriuretic doses of mineralocorticoid antagonist? Circ Heart Fail. 2009;2(4):370\u20136.","journal-title":"Circ Heart Fail"},{"key":"290_CR8","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1159\/000168356","volume":"11","author":"J Hensen","year":"1991","unstructured":"Hensen J, Abraham WT, Durr JA, Schrier RW. Aldosterone in congestive heart failure: analysis of determinants and role in sodium retention. Am J Nephrol. 1991;11:441\u20136.","journal-title":"Am J Nephrol"},{"key":"290_CR9","doi-asserted-by":"crossref","first-page":"3A","DOI":"10.1016\/0002-9149(93)90241-4","volume":"71","author":"AA Vliet van","year":"1993","unstructured":"van Vliet AA, Donker AJM, Nauta JJP, Verheugt FWA. Spironolactone in congestive heart failure refractory to high-dose loop diuretic and low-dose angiotensin converting enzyme inhibitor. Am J Cardiol. 1993;71:3A\u201311A.","journal-title":"Am J Cardiol"},{"issue":"3","key":"290_CR10","doi-asserted-by":"publisher","first-page":"e68","DOI":"10.1016\/j.ijcard.2013.11.023","volume":"170","author":"M Eng","year":"2014","unstructured":"Eng M, Bansal S. Use of natriuretic-doses of spironolactone for treatment of loop diuretic resistant acute decompensated heart failure. Int J Cardiol. 2014;170(3):e68\u20139.","journal-title":"Int J Cardiol"},{"issue":"9","key":"290_CR11","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1001\/jamacardio.2017.2198","volume":"2","author":"J Butler","year":"2017","unstructured":"Butler J, Anstrom KJ, Felker GM, Givertz MM, Kalogeropoulos AP, Konstam MA, Mann DL, Margulies KB, McNulty SE, Mentz RJ, Redfield MM, Tang WHW, Whellan DJ, Shah M, Desvigne-Nickens P, Hernandez AF, Braunwald E, National Heart Lung and Blood Institute Heart Failure Clinical Research Network. Efficacy and safety of spironolactone in acute heart failure: the ATHENA-HF Randomized Clinical Trial. JAMA Cardiol. 2017;2(9):950\u20138.","journal-title":"JAMA Cardiol"},{"issue":"8","key":"290_CR12","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1002\/ejhf.592","volume":"18","author":"P Ponikowski","year":"2016","unstructured":"Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonz\u00e1lez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P, Authors\/Task Force Members; Document Reviewers. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail. 2016;18(8):891\u2013975.","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"290_CR13","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ejim.2013.08.711","volume":"25","author":"JP Ferreira","year":"2014","unstructured":"Ferreira JP, Santos M, Almeida S, Marques I, Bettencourt P, Carvalho H. Mineralocorticoid receptor antagonism in acutely decompensated chronic heart failure. Eur J Intern Med. 2014;25(1):67\u201372.","journal-title":"Eur J Intern Med"},{"issue":"11","key":"290_CR14","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1093\/eurheartj\/ehm091","volume":"28","author":"A Ahmed","year":"2007","unstructured":"Ahmed A, Zannad F, Love TE, Tallaj J, Gheorghiade M, Ekundayo OJ, Pitt B. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J. 2007;28(11):1334\u201343.","journal-title":"Eur Heart J"},{"issue":"4","key":"290_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1093\/ehjcvp\/pvv026","volume":"1","author":"ML Krogager","year":"2015","unstructured":"Krogager ML, Eggers-Kaas L, Aasbjerg K, Mortensen RN, K\u00f8ber L, Gislason G, Torp-Pedersen C, S\u00f8gaard P. Short-term mortality risk of serum potassium levels in acute heart failure following myocardial infarction. Eur Heart J Cardiovasc Pharmacother. 2015;1(4):245\u201351.","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"issue":"12","key":"290_CR16","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1016\/j.amjcard.2016.08.078","volume":"118","author":"S Hoss","year":"2016","unstructured":"Hoss S, Elizur Y, Luria D, Keren A, Lotan C, Gotsman I. Serum potassium levels and outcome in patients with chronic heart failure. Am J Cardiol. 2016;118(12):1868\u201374.","journal-title":"Am J Cardiol"},{"issue":"5","key":"290_CR17","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.amjcard.2014.05.062","volume":"114","author":"A Maisel","year":"2014","unstructured":"Maisel A, Xue Y, van Veldhuisen DJ, Voors AA, Jaarsma T, Pang PS, Butler J, Pitt B, Clopton P, de Boer RA. Effect of spironolactone on 30-day death and heart failure rehospitalization (from the COACH Study). Am J Cardiol. 2014;114(5):737\u201342.","journal-title":"Am J Cardiol"},{"issue":"6","key":"290_CR18","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/ejhf.566","volume":"18","author":"MG Crespo-Leiro","year":"2016","unstructured":"Crespo-Leiro MG, Anker SD, Maggioni AP, Coats AJ, Filippatos G, Ruschitzka F, Ferrari R, Piepoli MF, Delgado Jimenez JF, Metra M, Fonseca C, Hradec J, Amir O, Logeart D, Dahlstr\u00f6m U, Merkely B, Drozdz J, Goncalvesova E, Hassanein M, Chioncel O, Lainscak M, Seferovic PM, Tousoulis D, Kavoliuniene A, Fruhwald F, Fazlibegovic E, Temizhan A, Gatzov P, Erglis A, Laroche C, Mebazaa A, Heart Failure Association (HFA) of the European Society of Cardiology (ESC). European Society of Cardiology Heart Failure Long-Term Registry (ESC-HF-LT): 1-year follow-up outcomes and differences across regions. Eur J Heart Fail. 2016;18(6):613\u201325.","journal-title":"Eur J Heart Fail"}],"container-title":["American Journal of Cardiovascular Drugs"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40256-018-0290-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-018-0290-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40256-018-0290-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,2]],"date-time":"2019-07-02T23:10:31Z","timestamp":1562109031000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40256-018-0290-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":18,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["290"],"URL":"https:\/\/doi.org\/10.1007\/s40256-018-0290-3","relation":{},"ISSN":["1175-3277","1179-187X"],"issn-type":[{"value":"1175-3277","type":"print"},{"value":"1179-187X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,3]]},"assertion":[{"value":"3 July 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"No external funding was used in the preparation of this article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Chris J. Kapelios, Maria Bonou, Paraskevi Vogiatzi, George Tzanis, Polyxeni Mantzouratou, Lars H. Lund, and John Barbetseas declare that they have no conflicts of interest that may be directly relevant to the content of this article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}